Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
58,272,553
-
Total 13F shares
-
59,110,077
-
Share change
-
-258,233
-
Total reported value
-
$1,463,036,585
-
Put/Call ratio
-
137%
-
Price per share
-
$24.75
-
Number of holders
-
142
-
Value change
-
-$8,921,651
-
Number of buys
-
63
-
Number of sells
-
62
Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share (AGIO) as of Q3 2023
As of 30 Sep 2023,
AGIOS PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share (AGIO) was held by
142 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,110,077 shares.
The largest 10 holders included
VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Bellevue Group AG, ARMISTICE CAPITAL, LLC, FARALLON CAPITAL MANAGEMENT LLC, Rock Springs Capital Management LP, JPMORGAN CHASE & CO, DIMENSIONAL FUND ADVISORS LP, and STATE STREET CORP.
This page lists
142
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.